Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Dual lineage tracing shows that glomerular parietal epithelial cells can transdifferentiate toward the adult podocyte fate.

Kaverina NV, Eng DG, Freedman BS, Kutz JN, Chozinski TJ, Vaughan JC, Miner JH, Pippin JW, Shankland SJ.

Kidney Int. 2019 Mar 29. pii: S0085-2538(19)30339-4. doi: 10.1016/j.kint.2019.03.014. [Epub ahead of print]

PMID:
31200942
2.

Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX.

Kaverina NV, Kadagidze ZG, Borovjagin AV, Karseladze AI, Kim CK, Lesniak MS, Miska J, Zhang P, Baryshnikova MA, Xiao T, Ornelles D, Cobbs C, Khramtsov A, Ulasov IV.

Oncogene. 2018 Nov;37(46):6069-6082. doi: 10.1038/s41388-018-0395-9. Epub 2018 Jul 10.

PMID:
29991800
3.

Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing.

Eng DG, Kaverina NV, Schneider RRS, Freedman BS, Gross KW, Miner JH, Pippin JW, Shankland SJ.

Kidney Int. 2018 May;93(5):1240-1246. doi: 10.1016/j.kint.2018.01.014. Epub 2018 Mar 23.

4.

Lineage tracing aged mouse kidneys shows lower number of cells of renin lineage and reduced responsiveness to RAAS inhibition.

Hamatani H, Eng DG, Kaverina NV, Gross KW, Freedman BS, Pippin JW, Shankland SJ.

Am J Physiol Renal Physiol. 2018 Jul 1;315(1):F97-F109. doi: 10.1152/ajprenal.00570.2017. Epub 2018 Feb 7.

5.

KISS1 tumor suppressor restricts angiogenesis of breast cancer brain metastases and sensitizes them to oncolytic virotherapy in vitro.

Platonov ME, Borovjagin AV, Kaverina N, Xiao T, Kadagidze Z, Lesniak M, Baryshnikova M, Ulasov IV.

Cancer Lett. 2018 Mar 28;417:75-88. doi: 10.1016/j.canlet.2017.12.024. Epub 2017 Dec 18.

PMID:
29269086
6.

Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy.

Kaverina N, Borovjagin AV, Kadagidze Z, Baryshnikov A, Baryshnikova M, Malin D, Ghosh D, Shah N, Welch DR, Gabikian P, Karseladze A, Cobbs C, Ulasov IV.

Autophagy. 2017;13(11):1905-1923. doi: 10.1080/15548627.2017.1360466. Epub 2017 Oct 5.

7.

WT1 Is Necessary for the Proliferation and Migration of Cells of Renin Lineage Following Kidney Podocyte Depletion.

Kaverina NV, Eng DG, Largent AD, Daehn I, Chang A, Gross KW, Pippin JW, Hohenstein P, Shankland SJ.

Stem Cell Reports. 2017 Oct 10;9(4):1152-1166. doi: 10.1016/j.stemcr.2017.08.020. Epub 2017 Sep 28.

8.

Tracking the stochastic fate of cells of the renin lineage after podocyte depletion using multicolor reporters and intravital imaging.

Kaverina NV, Kadoya H, Eng DG, Rusiniak ME, Sequeira-Lopez ML, Gomez RA, Pippin JW, Gross KW, Peti-Peterdi J, Shankland SJ.

PLoS One. 2017 Mar 22;12(3):e0173891. doi: 10.1371/journal.pone.0173891. eCollection 2017.

9.

Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion.

Roeder SS, Barnes TJ, Lee JS, Kato I, Eng DG, Kaverina NV, Sunseri MW, Daniel C, Amann K, Pippin JW, Shankland SJ.

Kidney Int. 2017 Apr;91(4):896-913. doi: 10.1016/j.kint.2016.10.015. Epub 2016 Dec 18.

10.

Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.

Ko K, Wang J, Perper S, Jiang Y, Yanez D, Kaverina N, Ai J, Liarski VM, Chang A, Peng Y, Lan L, Westmoreland S, Olson L, Giger ML, Chun Wang L, Clark MR.

Arthritis Rheumatol. 2016 Nov;68(11):2740-2751. doi: 10.1002/art.39744.

11.

CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy.

Ulasov IV, Kaverina NV, Ghosh D, Baryshnikova MA, Kadagidze ZG, Karseladze AI, Baryshnikov AY, Cobbs CS.

Oncotarget. 2017 Apr 18;8(16):25989-25999. doi: 10.18632/oncotarget.11175.

12.

Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage.

Lichtnekert J, Kaverina NV, Eng DG, Gross KW, Kutz JN, Pippin JW, Shankland SJ.

J Am Soc Nephrol. 2016 Dec;27(12):3611-3627. Epub 2016 Apr 14.

13.

Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources.

Kaverina NV, Eng DG, Schneider RR, Pippin JW, Shankland SJ.

Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1397-413. doi: 10.1152/ajprenal.00369.2015. Epub 2016 Apr 13.

14.

Cells of renin lineage express hypoxia inducible factor 2α following experimental ureteral obstruction.

Stefanska A, Eng D, Kaverina N, Pippin JW, Gross KW, Duffield JS, Shankland SJ.

BMC Nephrol. 2016 Jan 8;17:5. doi: 10.1186/s12882-015-0216-0.

15.

Interstitial pericytes decrease in aged mouse kidneys.

Stefanska A, Eng D, Kaverina N, Duffield JS, Pippin JW, Rabinovitch P, Shankland SJ.

Aging (Albany NY). 2015 Jun;7(6):370-82.

16.

Cells of renin lineage are adult pluripotent progenitors in experimental glomerular disease.

Pippin JW, Kaverina NV, Eng DG, Krofft RD, Glenn ST, Duffield JS, Gross KW, Shankland SJ.

Am J Physiol Renal Physiol. 2015 Aug 15;309(4):F341-58. doi: 10.1152/ajprenal.00438.2014. Epub 2015 Jun 10.

17.

MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo.

Ulasov I, Borovjagin AV, Kaverina N, Schroeder B, Shah N, Lin B, Baryshnikov A, Cobbs C.

Cancer Lett. 2015 Sep 1;365(2):240-50. doi: 10.1016/j.canlet.2015.06.002. Epub 2015 Jun 4.

PMID:
26052095
18.

Changes in glomerular parietal epithelial cells in mouse kidneys with advanced age.

Roeder SS, Stefanska A, Eng DG, Kaverina N, Sunseri MW, McNicholas BA, Rabinovitch P, Engel FB, Daniel C, Amann K, Lichtnekert J, Pippin JW, Shankland SJ.

Am J Physiol Renal Physiol. 2015 Jul 15;309(2):F164-78. doi: 10.1152/ajprenal.00144.2015. Epub 2015 May 27.

19.

Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis.

Eng DG, Sunseri MW, Kaverina NV, Roeder SS, Pippin JW, Shankland SJ.

Kidney Int. 2015 Nov;88(5):999-1012. doi: 10.1038/ki.2015.152. Epub 2015 May 20.

20.

Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy.

Ulasov IV, Shah N, Kaverina NV, Lee H, Lin B, Lieber A, Kadagidze ZG, Yoon JG, Schroeder B, Hothi P, Ghosh D, Baryshnikov AY, Cobbs CS.

Oncotarget. 2015 Feb 28;6(6):3977-87.

21.

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis.

Kinloch AJ, Chang A, Ko K, Henry Dunand CJ, Henderson S, Maienschein-Cline M, Kaverina N, Rovin BH, Salgado Ferrer M, Wolfgeher D, Liarski V, Haddon DJ, Utz PJ, Wilson PC, Clark MR.

Arthritis Rheumatol. 2014 Dec;66(12):3359-70. doi: 10.1002/art.38888.

22.

Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue.

Liarski VM, Kaverina N, Chang A, Brandt D, Yanez D, Talasnik L, Carlesso G, Herbst R, Utset TO, Labno C, Peng Y, Jiang Y, Giger ML, Clark MR.

Sci Transl Med. 2014 Apr 2;6(230):230ra46. doi: 10.1126/scitranslmed.3008146.

23.

Clinical significance of KISS1 protein expression for brain invasion and metastasis.

Ulasov IV, Kaverina NV, Pytel P, Thaci B, Liu F, Hurst DR, Welch DR, Sattar HA, Olopade OI, Baryshnikov AY, Kadagidze ZG, Lesniak MS.

Cancer. 2012 Apr 15;118(8):2096-105. doi: 10.1002/cncr.26525. Epub 2011 Sep 16.

24.

In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis.

Chang A, Henderson SG, Brandt D, Liu N, Guttikonda R, Hsieh C, Kaverina N, Utset TO, Meehan SM, Quigg RJ, Meffre E, Clark MR.

J Immunol. 2011 Feb 1;186(3):1849-60. doi: 10.4049/jimmunol.1001983. Epub 2010 Dec 27.

25.

[Afobazole effect on heart rate variability in rats with different behaviors in the "open field" test].

Kaverina NV, Popova EP, Iarkova MA, Seredenin SB.

Eksp Klin Farmakol. 2009 Jan-Feb;72(1):33-40. Russian.

PMID:
19334509
26.

[The role of vagal control in the action of propranolol on the chronotropic cardiac function].

Kaverina NV, Lyskovtsev VV, Popova EP, Lebedeva MA.

Eksp Klin Farmakol. 2008 Jan-Feb;71(1):36-8. Russian.

PMID:
18365485
28.

Antiarrhythmic properties of estrogens.

Matyushin AI, Kaverina NV, Shimanovskii NL, Turilova AI.

Bull Exp Biol Med. 2006 Mar;141(3):337-8.

PMID:
17073154
29.

[Effect of the class III antiarrhythmic drug nibentan in vagotonic atrial fibrillation].

Popova EP, Lyskovtsev VV, Kaverina NV.

Eksp Klin Farmakol. 2006 Jan-Feb;69(1):24-7. Russian.

PMID:
16579055
30.

[Effect of cardiocyclide on the electrophysiological parameters of heart in experiments with vagus nerve excitation in narcotized dogs].

Kaverina NV, Lyskovets VV, Popova EV.

Eksp Klin Farmakol. 2005 Jan-Feb;68(1):30-5. Russian.

PMID:
15786961
31.

[Antifibrillatory effect of antiarrhythmic drugs of various classes under conditions of activation of the parasympathetic nervous system].

Kaverina NV, Chichkanov GG, Tsorin IB.

Eksp Klin Farmakol. 2004 Nov-Dec;67(6):30-1. Russian.

PMID:
15707011
32.

[Activation of the sympathetic nervous system influences the antifibrillatory effect of class I antiarrhythmic drugs].

Kaverina NV, Chichkanov GG, Tsorin IB, Kirsanova GIu.

Eksp Klin Farmakol. 2004 Sep-Oct;67(5):17-8. Russian.

PMID:
15559629
33.

[Antiarrhythmic properties of 2-(2'-hydroxy-2')-substituted ethyl-1,2,3,4-octahydropyrrolo[1,2-a]pyrazines].

Filippova OV, Kryzhanovskiĭ SA, Peresada VP, Likhosherstov AM, Revenko SV, Kaverina NV, Reznikov KM.

Eksp Klin Farmakol. 2004 Jul-Aug;67(4):26-9. Russian.

PMID:
15500041
34.

[Pharmacology of antiarrhythmia agents: the new aspects].

Kaverina NV, Chichkanov GG.

Eksp Klin Farmakol. 2003 Mar-Apr;66(2):46-52. Russian.

PMID:
12962048
35.

[Anti-arrhythmia activity of estradiol valerate and estradiol nitrate].

Matiushin AI, Kaverina NV, Shimanovskiĭ NL, Rzheznikov VM, Turilova AI.

Eksp Klin Farmakol. 2003 May-Jun;66(3):26-8. Russian.

PMID:
12924228
36.

[2-(2'-hydroxy 2'-substituted) ethyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazines--a novel group of substances with anti-arrhythmia activity].

Filippova OV, Kryzhanovskiĭ SA, Peresada VP, Likhosherstov AM, Vititnova MB, Kaverina NV, Reznikov KM.

Eksp Klin Farmakol. 2003 May-Jun;66(3):21-5. Russian.

PMID:
12924227
38.

[Electrophysiological effects of ethacizine in experimental myocardial infarction and stimulation of sympathetic heart innervation].

Kaverina NV, Lyskovtsev VV, Popova EP.

Eksp Klin Farmakol. 2002 Nov-Dec;65(6):23-7. Russian.

PMID:
12596528
39.

[Binding of dicyclohexylamide derivatives of N-substituted aminocarboxylic acids with muscarinic cholinoreceptors and beta-adrenoreceptors].

Brusova EG, Kaverina NV, Likhosherstov AM.

Eksp Klin Farmakol. 2002 Sep-Oct;65(5):39-41. Russian.

PMID:
12596513
40.

[The effect of novel class III anti-arrhythmia agents cardiocyclide and nibentan during activation of cardiac beta-adrenoreceptors].

Turilova AI, Katsitadze NSh, Kaverina NV.

Eksp Klin Farmakol. 2002 Sep-Oct;65(5):29-30. Russian.

PMID:
12596510
41.

[Comparative study of the anti-arrhythmic activity of cardiocyclide and nibentan in hypersympathotonia and acute myocardial ischemia].

Vititnova MB, Kryzhanovskiĭ SA, Kaverina NV.

Eksp Klin Farmakol. 2002 Mar-Apr;65(2):24-6. Russian.

PMID:
12109286
42.

[Effect of the novel III class anti-arrhythmia preparation (AL-275) in experimental myocardium and sympathetic stimulation].

Kaverina NV, Lyskovtsev VV, Kishchuk EP.

Eksp Klin Farmakol. 2001 Jan-Feb;64(1):33-7. Russian.

PMID:
11544801
43.

[Effect of the sympathetic nervous system activation on the antifibrillatory efficacy of various anti-arrhythmia agents].

Kaverina NV, Chichkanov GG, Tsorin IB, Kirsanova GIu.

Eksp Klin Farmakol. 2000 Nov-Dec;63(6):22-3. Russian.

PMID:
11202504
44.

[The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].

Berdiaev SU, Paliani-Katsitadze NSh, Turilova AI, Kaverina NV, Likhosherstov AM, Lebedeva AS, Ogurtsov VA.

Eksp Klin Farmakol. 1999 Jul-Aug;62(4):26-9. Russian.

PMID:
10513331
45.

New aminocarboxamides with class III anti-arrhythmic activity.

Poppe H, Schindler R, Sauer W, Marx D, Bartsch R, Kaverina NV, Lichoscherstow AM, Sokolov SF, Lyskovtsev VV, Seredenin SB, Borisenko SA.

Arch Pharm (Weinheim). 1999 Jul;332(7):233-42.

PMID:
10450168
46.

[A new class-III antiarrhythmic preparation among the dicyclohexylamides of aminocarboxylic acids].

Kaverina NV, Lyskovtsev VV, Sokolov SF, Poppe H, Marx D, Kishchuk EP, Turilova AI, Likhosherstov AM, Tsorin IB, Chichkanov GG.

Vestn Ross Akad Med Nauk. 1998;(11):42-6. Russian.

PMID:
9889705
47.

[The pharmacology of the new combined anti-arrhythmia preparation metatsizin].

Kaverina NV, Chichkanov GG, Bugriĭ EM, Vititnova MB, Tolmacheva EA, Turilova AI, Kryzhanovskiĭ SA, Lyskovtsev VV, Rodionov AP, Beloborodov VL.

Eksp Klin Farmakol. 1998 Mar-Apr;61(2):33-6. Russian.

PMID:
9621171
48.

New 5-aminoacyl-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones with antiarrhythmic activity.

Poppe H, Kaverina NV, Lyskovzev VV, Egerland U, Sauer W, Lichoscherstow A, Rüger C, Skoldinow A.

Pharmazie. 1997 Nov;52(11):821-30.

PMID:
9399338
49.

[Anti-arrhythmia agents: results and outlook].

Kaverina NV.

Eksp Klin Farmakol. 1994 Nov-Dec;57(6):12-5. Review. Russian. No abstract available.

PMID:
7756947
50.

[A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].

Paliani-Katsitadze NSh, Berdiaev SIu, Turilova AI, Kaverina NV, Likhosherstov AM.

Eksp Klin Farmakol. 1994 May-Jun;57(3):15-7. Russian.

PMID:
8049618

Supplemental Content

Loading ...
Support Center